After NBXH treatment, the elevated cd302 was downregulated by one-third, indicating that NBXH regulated the host’s anti-TB responses by inhibiting the phagocytic and bactericidal activity of monocytes/macrophages. The gene discussed is CD302; the disease is tuberculosis.